Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

sell
Moleculin Biotech Inc

Start price
Target price
Perf. (%)
€0.47
01.02.24
-
01.02.25
-12.39%
21.03.24

StockNews.com 
01.02.24 50%
buy
Vertex Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€400.85
31.01.24
€470.15
31.01.25
11.80%
02.09.24

Truist Financial Co. 
31.01.24 50%
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€25.25
31.01.24
€41.47
31.01.25
7.27%
02.09.24

Cantor Fitzgerald 
31.01.24 50%
buy
Vertex Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€397.35
31.01.24
€515.17
31.01.25
12.78%
02.09.24

The Goldman Sachs Group, Inc. 
31.01.24 50%
buy
Intra-Cellular Therapies Inc.

Start price
Target price
Perf. (%)
€63.60
31.01.24
€79.15
31.01.25
4.56%
02.09.24

Royal Bank of Canada 
31.01.24 50%
sell
Vertex Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€400.05
31.01.24
€299.00
31.01.25
12.02%
02.09.24

Robert W. Baird 
31.01.24 50%
buy
Viking Therapeutics Inc

Start price
Target price
Perf. (%)
€22.48
31.01.24
-
29.02.24
230.87%
01.03.24

MBU 
31.01.24 50%
sell
Ionis Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€48.14
31.01.24
-
31.01.25
-10.49%
02.09.24

StockNews.com 
31.01.24 50%
buy
Ultragenyx Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€40.80
30.01.24
€62.74
30.01.25
27.45%
30.08.24

Robert W. Baird 
30.01.24 50%
buy
BioMarin Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€82.64
30.01.24
€95.95
30.01.25
-0.10%
02.09.24

Robert W. Baird 
30.01.24 50%
buy
Biogen Inc.

Start price
Target price
Perf. (%)
€227.80
30.01.24
€272.17
30.01.25
-18.48%
02.09.24

Oppenheimer Holdings Inc. 
30.01.24 50%
buy
Exelixis Inc.

Start price
Target price
Perf. (%)
€20.08
30.01.24
€23.07
30.01.25
16.14%
02.09.24

Barclays PLC 
30.01.24 50%
buy
Jazz Pharmaceuticals plc

Start price
Target price
Perf. (%)
€116.60
29.01.24
€217.33
29.01.25
-9.09%
02.09.24

Barclays PLC 
29.01.24 50%
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€877.50
29.01.24
€995.08
29.01.25
21.94%
02.09.24

Royal Bank of Canada 
29.01.24 50%
buy
Novavax Inc.

Start price
Target price
Perf. (%)
€3.75
29.01.24
-
29.01.25
-2.03%
03.02.24

Could be very worthwhile Investment >20% year
quelbe60 
29.01.24 50%
buy
Palisade Bio Inc.

Start price
Target price
Perf. (%)
€0.99
29.01.24
€1.00
29.01.25
-49.90%
03.02.24

Good culture
Capable Management
Could be worthwhile Investment >10% per year
Few uniques
me8 
29.01.24 0%
sell
Evoke Pharma Inc.

Start price
Target price
Perf. (%)
€0.57
29.01.24
-
29.01.25
-40.35%
31.07.24

StockNews.com 
29.01.24 50%
buy
Evolus Inc

Start price
Target price
Perf. (%)
€11.80
29.01.24
€14.78
29.01.25
22.03%
30.08.24

Barclays PLC 
29.01.24 50%
buy
AbbVie Inc.

Start price
Target price
Perf. (%)
€152.90
29.01.24
-
29.01.25
18.22%
02.09.24

William Blair 
29.01.24 50%
buy
Dr. Reddy's Laboratories Ltd. ADR

Start price
Target price
Perf. (%)
€64.00
29.01.24
€73.92
29.01.25
17.88%
30.08.24

Barclays PLC 
29.01.24 50%
buy
Teva Pharmaceutical Industries Ltd ADR

Start price
Target price
Perf. (%)
€11.00
29.01.24
€13.86
29.01.25
53.64%
02.09.24

Barclays PLC 
29.01.24 50%
buy
Dr. Reddy's Laboratories Ltd. ADR

Start price
Target price
Perf. (%)
€63.00
27.01.24
-
27.01.25
17.37%
30.08.24

StockNews.com 
27.01.24 50%
sell
Advaxis Inc.

Start price
Target price
Perf. (%)
€0.059
27.01.24
-
27.01.25
-
23.09.22

StockNews.com 
27.01.24 50%
buy
Amgen Inc.

Start price
Target price
Perf. (%)
€288.00
27.01.24
-
27.01.25
7.22%
02.09.24

StockNews.com 
27.01.24 50%
sell
Bellicum Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€0.079
27.01.24
-
27.01.25
-19.11%
05.03.24

StockNews.com 
27.01.24 50%